Glutamic Acid Decarboxylase (GAD65) Antibody
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms |
ANTI-GAD GLUTAMATE |
| Cerner Primary Mnemonic | Glutamic Acid Decarboxylase |
| EPIC Display Name | Glutamic Acid Decarboxylase (GAD65) Antibody |
| Allscripts (AEHR) Order Name | Glutamic Acid Decarboxylase Antibody |
| Sunrise Clinical Manager (SCM) Order Name | Glutamic Acid Decarboxylase Antibody |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
Glutamic Acid Decarboxylase |
| Clinical Info |
Assessing susceptibility to autoimmune (type 1, insulin-dependent) diabetes mellitus and related endocrine disorders (eg, thyroiditis and pernicious anemia) Distinguishing between patients with type 1 and type 2 diabetes Confirming a diagnosis of stiff-man syndrome, autoimmune encephalitis, autoimmune ataxia, brain stem encephalitis, autoimmune epilepsy, autoimmune myelopathy; titers generally greater than or equal to 20.0 nmol/L |
| Specimen Type |
Blood |
| Container |
Gold Top Tube |
| Collection Instructions |
Container/Tube: Red top or Gold Top Tube Specimen: 1.5 mL serum (1.0 mL min) |
| Transport Instructions |
Refrigerated |
| Specimen Stability |
72 Hours Room Temperature 28 Days Refrigerated or Frozen |
| Methodology |
Immunoprecipitation Assay (IPA) |
| Days Performed |
TAT: 4-7 Days |
| Performing Laboratory |
Mayo Medical Laboratories |
| CPT |
86341 LOINC Code 94345-6 |
| PDM |
5910600 |
Desired Epic Build Glutamic Acid Decarboxylase (GAD65) Antibody
| Cerner Primary Mnemonic: | Glutamic Acid Decarboxylase | ||||||
| PDM | 5910600 | ||||||
| Informatics - Workgroup | Chemistry | ||||||
| Synonyms * | ANTI-GAD GLUTAMATE | ||||||
| Display Name * | Glutamic Acid Decarboxylase (GAD65) Antibody | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | Assessing susceptibility to autoimmune (type 1, insulin-dependent) diabetes mellitus and related endocrine disorders (eg, thyroiditis and pernicious anemia) Distinguishing between patients with type 1 and type 2 diabetes Confirming a diagnosis of stiff-man syndrome, autoimmune encephalitis, autoimmune ataxia, brain stem encephalitis, autoimmune epilepsy, autoimmune myelopathy; titers generally greater than or equal to 20.0 nmol/L | ||||||
| IP Orderable | Yes | ||||||
| OP Orderable | Yes | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | |||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Actual Epic build
| Procedure Id | 64548 | ||||||||||||||||||||||||
| Pdm | 5910600 | ||||||||||||||||||||||||
| Order Display Name | Glutamic Acid Decarboxylase (GAD65) Antibody | ||||||||||||||||||||||||
| Procedure Name | GLUTAMIC ACID DECARBOXYLASE | ||||||||||||||||||||||||
| Procedure Master Number | LAB650 | ||||||||||||||||||||||||
| Short Procedure Name | GLUTAMIC ACID DECARBOXYL | ||||||||||||||||||||||||
| Category Code | 1.0 | ||||||||||||||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||||||||||||||
| Synonyms | ANTI-GAD GLUTAMATE | ||||||||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||||||||
| Performable | Yes | ||||||||||||||||||||||||
| Filter Genomics | |||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/64548 | ||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source List | |||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||
| Ip Lab Test Components For Report | |||||||||||||||||||||||||
| Op Lab Test Components For Report | |||||||||||||||||||||||||
| Order Questions | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||
| Order Questions Record Name | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||
| Inpatient Order Questions | [] | ||||||||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||||||||
| Order Specific Question Override | Yes | ||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||
| Derived Edp Ip Buttons S | Blood, Capillary Blood, Venous Blood, Central Line Blood, Arterial | ||||||||||||||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||||||||
EPIC Components (results)
| |||||||||||||||||||||||||